Dr. Luhan Yang is a scientific entrepreneur who pioneered genome editing technology and is passionate about changing the world for better. She is led the efforts of creating human transplantable organs and cells using genome editing approach at eGenesis ( Cambridge, USA) and Qihan ( Hangzhou, China).

She previously developed the highly programmable genome-engineering tool, CRISPR/Cas9, and pioneered the first isogenic human stem cell lines to model human diseases at the tissue level. She was recently honored as one of the Visionaries of Our Time ( NYT, 2018) and the Most Influential 50 People (Bloomberg, 2017) and was among “30 Under 30” in Science and Healthcare by Forbes Magazine (2014). Dr. Yang holds B.S. degrees in Biology and Psychology from Peking University and a Ph.D. in Human Biology and Translational Medicine from Harvard Medical School.

President & CSO of eGenesis until 2019.